MASI Learn · Healthy aging systems
Brain health and cognitive longevity
The practical answer: protect cognition with regular exercise, sufficient sleep, treatment of hearing or vision loss, social and cognitive activity, and control of vascular risk. A MASI supplement program can complement those foundations by supporting NAD+ metabolism and selected polyphenol or autophagy pathways, but it is not a treatment for memory loss or dementia.
Start with the interventions that affect the whole brain
Cognitive aging is shaped by several systems at once: cerebral blood flow, glucose and lipid regulation, sleep-dependent memory processing, sensory input, mood, and the brain’s ability to adapt to challenge. That is why the best starting program is broad rather than capsule-led.
- Move most days. Combine aerobic work with resistance training and balance practice. Exercise supports cardiovascular fitness, strength, insulin sensitivity, and independence—the same systems that influence long-term brain health.
- Protect sleep. Persistent insomnia, loud snoring, witnessed apnoea, or daytime sleepiness deserve clinical assessment rather than a supplement workaround.
- Correct sensory loss. Hearing and vision affect how much useful information reaches the brain and how easily a person stays socially engaged.
- Manage clinical risk. Blood pressure, diabetes, lipids, smoking, depression, and medication burden belong in routine care.
In the two-year FINGER randomized trial, a multidomain program combining diet, exercise, cognitive training, and vascular-risk monitoring improved or maintained cognitive performance better than general health advice in at-risk older adults. This supports a program approach, not a single-molecule promise. Read the trial.
What human studies can—and cannot—tell us
Trials of lifestyle or nutritional interventions usually measure specific cognitive tests, blood-flow measures, or biomarkers over months to a few years. A change in one test is not proof that an intervention prevents dementia. Results also depend on baseline health, age, dose, and study duration.
A randomized trial of mindfulness training and exercise in older adults did not show a significant improvement in episodic memory or executive function versus controls, illustrating why plausible interventions still need outcome-specific evidence. Read the trial.
For MASI-adjacent molecules, evidence is narrower. A 24-month resveratrol trial in postmenopausal women reported changes in cognition and cerebrovascular measures, but it does not establish a universal cognitive benefit. Read the trial. A randomized spermidine study in older adults with subjective cognitive decline did not justify treating spermidine as a dementia therapy. Read the trial.
Choosing a MASI program
Best fit for broad cellular-energy support: MASI NMN, used according to its label, is the clearest starting point for customers whose main goal is NAD+ precursor support. Human NMN trials show that oral NMN can raise NAD-related measures, while functional outcomes remain study-specific. Learn more in NMN and NAD+ biology.
Best fit for a polyphenol layer: MASI Resveratrol adds a distinct polyphenol research lane. It is most useful as a deliberate addition to an established program, not as a claim to restore memory. See resveratrol evidence and use.
Best fit for an autophagy-focused lane: MASI Spermidine is relevant to customers interested in polyamine and autophagy biology. Human cognitive evidence is still limited, so the product role is pathway support rather than neurological treatment. See spermidine biology.
A practical 90-day plan is to choose one primary goal, begin with one core product, keep exercise and sleep routines stable, and assess tolerability and adherence before adding another molecule. Track useful outcomes such as training consistency, sleep regularity, and everyday function—not day-to-day feelings alone.
When clinical assessment comes first
New or rapidly worsening confusion, weakness, speech difficulty, severe headache, fainting, or sudden functional change needs urgent medical assessment. Gradual memory change also deserves a clinician’s review because sleep disorders, depression, thyroid disease, vitamin deficiencies, medication effects, and neurological conditions can overlap. Discuss supplements with a clinician or pharmacist if you use anticoagulants, antiplatelet medicines, diabetes medicines, or multiple prescriptions.
Frequently asked questions
Which MASI product should I start with for healthy cognitive aging?
For a generally healthy adult seeking a simple cellular-energy program, NMN is the most direct first choice because its role as an NAD+ precursor is clear. Resveratrol or spermidine can be added for a distinct research interest, but adding more products is not automatically better. Choose according to the pathway you want to support and review medicines first.
How long should I use a program before assessing it?
Ninety days is a practical adherence window for a supplement program, provided the product label and your clinical context allow it. It is long enough to judge routine, tolerability, and whether the program fits your training and sleep habits. It is not a diagnostic test and should not delay assessment of cognitive symptoms.
Can supplements prevent dementia?
No MASI supplement is established to prevent or treat dementia. The strongest practical approach is multidomain: exercise, cardiovascular risk management, sleep, sensory care, social engagement, and appropriate clinical evaluation. Supplements can sit alongside that plan as nutritional or pathway support.
Can NMN, resveratrol, and spermidine be used together?
They target different research pathways and may be used in the same longevity program by some adults, but compatibility depends on health conditions and medicines. Start sequentially rather than all at once, follow each label, and ask a clinician or pharmacist to review the combination when prescriptions or bleeding risk are relevant.
Build a 90-day MASI program or compare the individual molecules in the MASI Learn library.